banter and General Discussion, page-17327

We used to defend the science and the personal risk we chose to take on when investing in a biotech.

The detractors were few but they were relentless and in the end were made to look foolish.


Now the detractors are plentiful , ignorant and cannot comprehend how the roll out is staged. They have zero interest re the upcoming CHF meeting and wait fearfully for proof that Ryoncil is selling, some question whether it is even working.


When they raise such stupidity I have become an expert at placing them on ignore. That is why I don't engage as much anymore, I'm not following the conversations the regulars are engaging in.


Ryoncil was approved, efficacy was never in doubt. It's rolling out, sales will shortly exceed ,annualised, US $100 million then we get Europe, off label and adult trial still to come. Tick tick boom.



Personally I think those questioning Ryoncil's rollout are imbeciles. It was an unmet need and we have the market to ourselves for 7 years! I'm now here for CHF- with the regime change and pro new therapy team to Make America Health Again I think we are extremely well placed for a possible Accelerated Approval- which will partner us with a Global giant. Global being the key word here. 80% reduction in heart attacks for heart failure patients with elevated CRP being sold across the world. My mind boggles at the opportunity as reference pricing for Ryoncil tripled expectations.


Ryoncil is derisked, Revascor in now in play. I'm excited.



You do you........................................... those on ignore deserve each other






Reg